Atlas Trials

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Clinical trial NCT05979792 · UNKNOWN

Trial details

NCT number
NCT05979792
Sponsor
Zhao Weili
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma
Start date
2023-09-01
Primary completion
2025-08-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.